| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |